Agritek Holdings, Inc. (AGTK)
- Previous Close
0.0001 - Open
0.0001 - Bid --
- Ask --
- Day's Range
0.0001 - 0.0001 - 52 Week Range
0.0001 - 0.0001 - Volume
27,293 - Avg. Volume
3,048 - Market Cap (intraday)
6,386 - Beta (5Y Monthly) 25.74
- PE Ratio (TTM)
-- - EPS (TTM)
-0.5700 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Agritek Holdings, Inc. distributes hemp and cannabis products under the Hemp Pops, MD Vapes, Rehab Rx, Higher Society, and California Premiums brands in the United States. Its products include human ingestible, such as tinctures, capsules, and gummies; CBD edibles; topicals; and pet products. The company also offers business services, including operational and compliance consulting, funding and financing, dispensary and retail, commercial production and equipment build out, multichannel supply chain, and consumer product, as well as branding, marketing, and sales solutions. In addition, it is involved in the acquisition and leasing of real estate properties, such as cultivation space and related facilities to licensed marijuana growers and dispensary owners. Agritek Holdings, Inc. distributes its products through e-commerce websites comprising RehabRx.com and Hemppops.com; third-party e-commerce websites; and various brick and mortar retailers. The company was formerly known as MediSwipe Inc. and changed its name to Agritek Holdings, Inc. in April 2014. Agritek Holdings, Inc. was incorporated in 1997 and is headquartered in Miami, Florida.
www.agritekholdings.comRecent News: AGTK
View MorePerformance Overview: AGTK
Trailing total returns as of 11/21/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: AGTK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: AGTK
View MoreValuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-555.78%
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-8.05M
Diluted EPS (ttm)
-0.5700
Balance Sheet and Cash Flow
Total Cash (mrq)
342.3k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
1.99M